Congenital coarctation of the aorta is an obstructive malformation of the thoracic aortic tract, characterized by a segmental narrowing of the aortic lumen, usually located near the isthmus, between the origin of the left subclavian artery and the ductus arteriosus (or the residual ligamentum arteriosum). It accounts for approximately 5–8% of all congenital heart defects, with an estimated incidence of 4 cases per 10,000 live births. It may present as an isolated lesion or, more frequently, be associated with other cardiovascular anomalies, particularly a bicuspid aortic valve or septal defects.
Aortic narrowing results in a pressure gradient between the proximal and distal aorta, with systemic hypertension in the upper body and hypoperfusion in the lower limbs. The severity of the coarctation can vary significantly: from mild, asymptomatic forms discovered incidentally to critical neonatal forms requiring urgent treatment to prevent hemodynamic collapse. Early identification and prompt treatment are essential to prevent long-term complications such as left ventricular hypertrophy, organ dysfunction, and sudden death.
Aortic coarctation is a congenital malformation with an etiological basis in a localized alteration of the normal embryological development of the aortic arch. This process, occurring between the fourth and eighth week of gestation, involves the formation of the definitive aortic arch and the selective regression of some segments of the six primitive branchial arches. An error in this remodeling may lead to the persistence of abnormal ductal tissue or uneven growth of the aortic wall, resulting in a focal narrowing typically at the isthmic level.
In many cases, the stenotic segment contains smooth muscle tissue similar to that of the ductus arteriosus, which tends to contract after birth, further aggravating the narrowing. The process may occur in isolation, but it is frequently associated with other structural anomalies. The most common is a bicuspid aortic valve, present in 50–85% of patients with coarctation, suggesting a shared embryological origin between the two conditions.
In addition to confirmed embryological causes, there are risk factors that increase the likelihood of developing aortic coarctation, although they are not direct causes. These include:
The main pathogenic mechanism is the progressive reduction of the aortic diameter at the isthmic level, which is accentuated after birth due to closure of the ductus arteriosus and contraction of the residual ductal tissue. This results in a mechanical obstruction to blood flow from the left ventricle to the systemic circulation. In severe cases, flow through the coarcted segment becomes critical, and perfusion of the descending aorta largely depends on ductal patency.
From a pathophysiological perspective, coarctation causes increased left ventricular afterload, leading to compensatory hypertrophy and subsequent diastolic dysfunction. Blood faces high resistance downstream of the obstruction, resulting in an asymmetric distribution of arterial pressure: hypertension in upstream regions (upper limbs, brain) and hypotension in downstream regions (lower limbs, abdominal organs). In neonates, this imbalance may rapidly lead to hypoperfusive shock, lactic acidosis, and multiorgan failure upon ductal closure.
Over time, even in non-critical patients, coarctation can lead to persistent systemic hypertension, left ventricular dysfunction, post-coarctation aneurysms, and an increased risk of sudden death. The presence of associated lesions, such as bicuspid valve or ascending aortic dilatation, further worsens the prognosis and requires careful and long-term monitoring.
The clinical presentation of congenital aortic coarctation is strongly influenced by three main variables: the degree of aortic narrowing, the patient's age at diagnosis, and the extent of collateral circulation development. In mild or compensated forms, the patient may remain asymptomatic for years; conversely, in neonates with critical coarctation, closure of the ductus arteriosus can precipitate a dramatic picture of hypoperfusive shock.
In full-term neonates, the initial period may appear normal thanks to the patency of the ductus arteriosus, which ensures retrograde flow to the descending aorta. However, with physiological closure of the ductus (within the first 48–72 hours of life), systemic flow rapidly collapses, leading to:
This clinical picture constitutes a neonatal emergency, in which pharmacologic maintenance of the ductus arteriosus through prostaglandin E1 (PGE1) infusion represents the first life-saving intervention, pending echocardiographic confirmation and definitive treatment.
In infants or young children with severe but non-critical coarctation, symptoms may be subtler and progress over time. Common clinical signs include:
In older children and adolescents, coarctation may manifest as hypertension in the upper limbs, often incidentally detected during pediatric evaluation. In these patients, symptoms are dominated by signs of hypertension and upper-lower circulation disparity:
The physical examination provides key elements for diagnostic suspicion. The most significant findings include:
In some adolescents or young adults, coarctation may go unrecognized until the occurrence of sudden death, severe left ventricular hypertrophy, or post-stenotic aneurysms. This highlights the importance of systematic blood pressure measurement in all limbs and echocardiographic assessment in individuals with juvenile hypertension, suspicious murmurs, or a family history of congenital heart disease.
The diagnosis of congenital coarctation of the aorta is based on the integration of clinical, semiological, and instrumental findings, with the aim of early identification of critical neonatal forms and recognition of subclinical presentations in older children. Suspicion typically arises from a systolic murmur in the paravertebral area or a significant blood pressure difference between upper and lower limbs. In neonates, coarctation may manifest after ductal closure with a picture of sudden shock refractory to conventional therapy.
In symptomatic patients, systematic blood pressure measurement in both upper limbs and at least one lower limb is essential. The presence of reduced systolic pressure in the lower limbs associated with weak or absent femoral pulses is a pathognomonic sign.
Pulse oximetry may reveal discordant pre- and post-ductal oxygen saturation in neonates, suggesting abnormal blood shunting.
The electrocardiogram shows nonspecific findings in neonates, but in older children may reveal left ventricular hypertrophy with tall R waves in lateral leads (V5–V6) and deep S waves in V1.
The chest X-ray may be normal or show a mildly enlarged heart with signs of pulmonary congestion in cases of heart failure. In older children, rib notching—indentations of the posterior ribs due to hyperflow in collateral intercostal arteries—may be evident.
The key diagnostic tool is transthoracic echocardiography, which allows accurate assessment of:
The systolic gradient is calculated using the modified Bernoulli equation. Although a gradient > 20 mmHg is suggestive, the numerical value must always be interpreted in the clinical context: high gradients may be falsely low in neonates with low cardiac output or a large ductus arteriosus. Therefore, anatomical assessment of the isthmic region is crucial even in the absence of significant gradients.
Cardiac magnetic resonance imaging (MRI) is the non-invasive gold standard in older children and adolescents. It provides accurate three-dimensional reconstruction of the aortic arch, measurement of the coarcted segment, and evaluation of collateral vessel flow. It is especially useful in postoperative follow-up and surgical planning.
Multislice cardiac computed tomography (CT) may be used when MRI is contraindicated or unavailable, offering high-resolution images of vascular structures and the aortic wall.
Cardiac catheterization, once a diagnostic standard, is now reserved for complex cases or for balloon angioplasty in selected patients.
The differential diagnosis in neonatal cases includes septic shock, late-onset sepsis, ductal closure in complex heart disease, and aortic hypoplasia. Rapid identification via echocardiography and early prostaglandin administration allow effective stabilization while awaiting definitive correction.
The therapeutic management of congenital coarctation of the aorta depends on the patient’s age, severity of obstruction, presence of clinical symptoms, and associated anomalies. In critical neonatal forms, treatment is a pediatric emergency, whereas in older patients with mild or moderate coarctation, a conservative strategy with structured follow-up may be adopted. The primary goal is to restore effective aortic flow, prevent hypertension-related complications, and correct any associated lesions.
In neonates with critical coarctation, the first life-saving measure is continuous intravenous administration of prostaglandin E1 (PGE1) to maintain ductal patency, temporarily ensuring systemic blood flow. This allows stabilization of the hemodynamic condition pending surgical correction.
Surgery is the treatment of choice in most cases. The main techniques include:
In older children and adolescents with isolated coarctation and favorable anatomy, balloon angioplasty, with or without stent placement, may be considered. This technique effectively reduces the gradient and restores flow, but carries a higher risk of re-stenosis in younger patients and post-dilation aneurysms in older ones.
Criteria for intervention include:
Long-term follow-up is essential to monitor hemodynamic evolution and prevent complications. Periodic evaluations should assess:
The prognosis is generally favorable in patients treated promptly and appropriately. However, about 30–40% of individuals may develop persistent hypertension even after anatomical correction, due to alterations in aortic compliance or baroreceptor function. The risk of re-stenosis is higher in neonates treated early, especially with percutaneous techniques.
In untreated cases, or where correction is delayed, there is an increased risk of left ventricular dysfunction, post-coarctation aneurysms, ascending aortic dilatation, and sudden death, especially in the presence of a bicuspid aortic valve. For this reason, lifelong structured monitoring is essential, even for patients successfully operated on in childhood.
Congenital coarctation of the aorta, if inadequately treated or diagnosed late, can lead to significant short- and long-term complications. The nature of complications depends on the severity of obstruction, age at diagnosis, type of treatment, and presence of associated anomalies, particularly a bicuspid aortic valve.
In untreated patients, the main complication is the development of systemic arterial hypertension, which can arise even in childhood and persist after anatomical correction. This phenomenon is related to vascular remodeling and altered baroreceptor response, potentially causing organ damage to the heart, kidneys, and brain.
Another relevant complication is left ventricular dysfunction, initially diastolic due to reduced compliance from hypertrophy, but potentially evolving to systolic dysfunction. In severe or late-treated cases, this may lead to chronic heart failure, especially in the presence of functional mitral regurgitation.
Among the most feared complications is sudden death, attributed to malignant ventricular arrhythmias or myocardial ischemia from pressure overload. Risk increases in uncorrected patients, those with bicuspid valve and ascending aortic dilatation, and in individuals with severe ventricular hypertrophy or exertional syncope.
Following surgical or percutaneous treatment, the most frequent complications include:
Progressive dilation of the ascending aorta is a long-term risk in patients with a bicuspid valve, even in the absence of significant stenosis. This condition predisposes to aortic dissection and requires radiological surveillance with periodic MRI or CT, and early surgical indication in case of critical diameters or rapid progression.
Finally, in patients with multiple reinterventions or residual ventricular dysfunction, atrial or ventricular arrhythmias, exercise intolerance, and the need for chronic pharmacologic therapy may develop. For these reasons, a structured and permanent cardiologic follow-up is essential, including blood pressure monitoring, advanced imaging, and evaluation of ventricular function.